GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QuantaMatrix Inc (XKRX:317690) » Definitions » EV-to-FCF

QuantaMatrix (XKRX:317690) EV-to-FCF : -5.58 (As of Apr. 23, 2025)


View and export this data going back to 2020. Start your Free Trial

What is QuantaMatrix EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, QuantaMatrix's Enterprise Value is ₩75,080 Mil. QuantaMatrix's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-13,463 Mil. Therefore, QuantaMatrix's EV-to-FCF for today is -5.58.

The historical rank and industry rank for QuantaMatrix's EV-to-FCF or its related term are showing as below:

XKRX:317690' s EV-to-FCF Range Over the Past 10 Years
Min: -29.63   Med: -4.24   Max: -2.22
Current: -5.63

During the past 8 years, the highest EV-to-FCF of QuantaMatrix was -2.22. The lowest was -29.63. And the median was -4.24.

XKRX:317690's EV-to-FCF is ranked worse than
100% of 387 companies
in the Medical Devices & Instruments industry
Industry Median: 24.96 vs XKRX:317690: -5.63

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-23), QuantaMatrix's stock price is ₩3955.00. QuantaMatrix's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-1220.000. Therefore, QuantaMatrix's PE Ratio (TTM) for today is At Loss.


QuantaMatrix EV-to-FCF Historical Data

The historical data trend for QuantaMatrix's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QuantaMatrix EV-to-FCF Chart

QuantaMatrix Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial -19.24 -6.80 -2.51 -3.03 -8.20

QuantaMatrix Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.03 -2.79 -3.61 -10.36 -8.20

Competitive Comparison of QuantaMatrix's EV-to-FCF

For the Medical Devices subindustry, QuantaMatrix's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QuantaMatrix's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QuantaMatrix's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where QuantaMatrix's EV-to-FCF falls into.


;
;

QuantaMatrix EV-to-FCF Calculation

QuantaMatrix's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=75079.750/-13462.63
=-5.58

QuantaMatrix's current Enterprise Value is ₩75,080 Mil.
QuantaMatrix's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-13,463 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


QuantaMatrix  (XKRX:317690) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

QuantaMatrix's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3955.00/-1220.000
=At Loss

QuantaMatrix's share price for today is ₩3955.00.
QuantaMatrix's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1220.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


QuantaMatrix EV-to-FCF Related Terms

Thank you for viewing the detailed overview of QuantaMatrix's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


QuantaMatrix Business Description

Traded in Other Exchanges
N/A
Address
131, Gasan digital 1-ro, Geumcheon-gu, 16th floor, Bidong (Gasan-dong, BYC High City), Seoul, KOR, 08506
QuantaMatrix Inc is engaged in research and development, production, and sales of in vitro diagnostic (IVD) medical devices that utilize substances collected from the human body, such as blood, feces, body fluids, and saliva, for the purpose of disease prevention and diagnosis, prognosis prediction, and assessment of health status and treatment effectiveness, targeting domestic and foreign general hospitals and testing contract institutions.

QuantaMatrix Headlines

No Headlines